Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA

Cancer Research

Volumn 58, Issue 15, 1998, Pages 3362-3369

  Tanaka, Toshihide ^a   Cao, Yihai ^b,c   Folkman, Judah ^b   Fine, Howard A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; COMPLEMENTARY DNA; VIRUS VECTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; GENE THERAPY; GLIOBLASTOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; TUMOR VASCULARIZATION;

ADENOVIRIDAE; ANGIOSTATINS; ANIMALS; BLOTTING, NORTHERN; BRAIN NEOPLASMS; CELL DIVISION; DNA, COMPLEMENTARY; GENE THERAPY; GENETIC VECTORS; GLIOBLASTOMA; GLIOMA; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PLASMINOGEN; RATS; RATS, INBRED F344; TRANSFECTION;

EID: 0032145376     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Takahashi, J., Mori, H., and Fukumoto, M. Gene expression of fibroblast growth factors in human gliomas and meningiomas. Proc. Natl. Acad. Sci. USA, 87: 5710-5714, 1990.
2. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
3. Plate, K. H., Breire, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
4. Maxwell, M., Naber, S. P., Wolfe, H. J., Hedley-Whyte, E. T., Galanopoulos, T., Neville-Golden, J., and Antoniades, T. Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res., 51: 1345-1351, 1991.
5. Hsu, S. C., Volpert, O. V., Steck, P. A., Mikkelson, T., Polverini, P. J., Rao, S., Chou, P., and Bouck, N. P. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin. Cancer Res., 56: 5684-5691, 1996.
6. Brem, S. S., Zagzag, D., Tsanaclis, A. M. C., Gately, S., Elkouby, M-P., and Brien, S. E. Inhibition of angiogenesis and tumor growth in the brain. Am. J. Pathol., 137: 1121-1142, 1990.
7. Tamargo, R. J., Leong, K. W., and Brem, H. Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate. J. Neurooncol., 9: 131-138, 1990.
8. Lee, J. K., Choi, B., Sobel, R. A., Chiocca, E. A., and Martuza, R. L. Inhibition of growth and angiogenesis of human neurofibrosarcoma by heparin and hydrocortisone. J. Neurosurg., 73: 429-435, 1990.
9. Gross, J. L., Hertel, D., Herglin, W. F., Neville, M., and Brem, S. S. Inhibition of basic fibroblast growth factor-induced angiogenesis and glioma tumor growth in vivo in copper depleted rats (meeting abstract). Proc. Am. Assoc. Cancer Res. Annu. Meet., 32: A338, 1991.
10. Takamiya, Y., Friedlander, R. M., Brem, H., Malick, A., and Martuza, R. L. Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470. J. Neurosurg., 78: 470-476, 1993.
11. Takamiya, Y., Brem, H., Ojeifo, J., Mineta, T., and Martuza, R. L. AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo. Neurosurgery, 34: 869-875, 1994.
12. Tanaka, T., Manome, Y., Wen, P., Dufe, D. W., and Fine, H. A. Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth. Nat. Med., 3: 1-6, 1997.
13. Tanaka, T., Manome, Y., Kufe, D., Folkman, J., and Fine, H. Viral vector mediated transfer of angiostatin for the treatment of malignant gliomas. Proc. Am. Assoc. Cancer Res. Annu. Meet., 38: 269, 1997.
14. Manome, Y., Wen, P. Y., Hershowitz, A., Tanaka, T., Rollins, B. J., Kufe, D., and Fine, H. A. Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors. Cancer Immunol. Immunother., 41: 227-235, 1995.
15. Dong, Y., Wen, P. W., Manome, Y., Parr, M., Hershowitz, A., Chen, L., Hershowitz, E., Crystal, R., Kufe, D. W., and Fine, H. A. In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum. Gene Ther., 7: 713-720, 1996.
16. Manome, Y., Wen, P. Y., Chen, L., Tanaka, T., Dong, Y., Yamazoe, M., Hershowitz, A., Kufe, D. W., and Fine, H. A. Gene therapy for malignant gliomas using replication incompetent retroviral and adenoviral vectors encoding the cytochrome P4502B1 gene together with cyclophosphamide. Gene Ther., 3: 513-520, 1996.
17. Manome, Y., Wen, P. Y., Dong, Y., Tanaka, T., Mitchell, B. S., Kufe, D. W., and Fine, H. F. Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of 1-β-D-arabinofuranosylcytosine in vitro and in vivo. Nat. Med., 2: 567-573, 1996.
18. Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285: 1182-1186, 1971.
19. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
20. Maxwell, M., Naber, S. P., Wolfe, H. J., Galanopoulos, T., Hedley-White, E. T., Black, P. M., and Antoniades, H. N. Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J. Clin. Invest., 86: 131-140, 1990.
21. Dameron, K. M., Volpert, O. V., Tainsky, M. A., and Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science (Washington DC), 265: 1582-1584, 1994.
22. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiostatin inhibitor that mediates the suppression of metastases by a Lewis Lung carcinoma. Cell, 79: 315-328, 1994.
23. O'Reilly, M. S., Holmgren, L., Chen, C., and Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med., 2: 689-692, 1996.
24. Holmgren, L., O'Reilly, M. S., and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1: 149-153, 1995.